Cancer and Syria in conflict: a systematic review
2024

Cancer and Syria in Conflict: A Systematic Review

Sample size: 28 publication Evidence: low

Author Information

Author(s): Basha Lena, Ahmed Hamza, Hamze Mohamed, Ali Amaar Awais, Alahdab Fares, Marzouk Manar, Sullivan Richard, Abbara Aula

Primary Institution: Syrian American Medical Society, Washington, DC, US

Hypothesis

What is described in the academic and grey literature about the burden of cancer during the conflict in Syria?

Conclusion

The study highlights significant disparities in access to oncology services in Syria, particularly concentrated in Damascus, and emphasizes the need for high-quality data to inform policy and improve cancer care.

Supporting Evidence

  • Over 5,800 studies were identified, but only 28 met the inclusion criteria.
  • Most cancer services are concentrated in Damascus, leading to inequities in access.
  • High-quality data on cancer burden in Syria is lacking, complicating effective policy-making.
  • Patients often present with advanced stages of cancer due to delays in diagnosis and treatment.

Takeaway

The war in Syria has made it really hard for people with cancer to get the help they need, especially since most services are only available in the capital city, Damascus.

Methodology

A systematic review of literature from eight academic and six grey literature databases, focusing on studies published from March 2011 to February 2024.

Potential Biases

Potential biases due to the lack of comprehensive data and reliance on studies from specific regions.

Limitations

The review faced challenges due to the heterogeneity of outcome measures and limited high-quality data, particularly from regions outside of Damascus.

Participant Demographics

The review included studies on oncology patients of all ages and ethnicities located within Syria.

Digital Object Identifier (DOI)

10.1186/s12885-024-13256-9

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication